Establishment of collecting method for minimum sample in the EUS-FNA diagnosis of pancreatic cnacer using the rapid diagnostic apparatus

Establishment of collecting method for minimum sample in the EUS-FNA diagnosis of pancreatic cnacer using the rapid diagnostic apparatus - Establishment of collecting method for minimum sample in the EUS-FNA diagnosis of pancreatic cnacer using the rapid diagnostic apparatus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038665

Enrollment

Registered

2019-11-24

Start date

2019-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic disease

Interventions

EUS-FNA Consecutive patients with suspicious pancreatic carcinoma who are referred for EUS-FNA sampling at Jikei University Hospital are prospectively recruited in this study between November 25, 201

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Presence of a suspicious pancreatic carcinoma which was detected by at least a single investigational modality such as computed tomography, magnetic resonance imaging or EUS, and patients with suspicious pancreatic carcinoma who were referred for EUS-FNA sampling at Jikei University Hospital. 2.Performance status; 0,1 and 2. 3.patients <=20 years old. 4.provision of written informed consent to participate in the present study.

Exclusion criteria

Exclusion criteria: 1.internal use of an antiplatelet or anticoagulant agent. 2.Patients with pregnancy and/or suspected. 3.Patients with inability to participate in this study owing to psychiatric disorder. 4.Patints who reject to participate in this study. 5.The situation of difficulty to start or or continue the EUS-FNA.

Design outcomes

Primary

Measure	Time frame
To diagnosis pancreatic cancer by the rapid diagnostic apparatus, we will establish the collecting method for more than 30mg/ml of the total protein concentrationin from EUS-FNA sample.	—

Countries

Japan

Contacts

Public ContactMasafumi Chiba

The Jikei University School of Medicine Departments of Endoscopy

ccl09720@gmail.com03-3433-1111(3181)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026